Klacid (Clarithromycin)

Klacid is a macrolide antibiotic used to treat bacterial infections in several organ systems.

• Community‑acquired pneumonia: clears bacterial infection of the lungs and improves respiratory function.
• Acute bacterial sinusitis: reduces sinus inflammation and bacterial load, relieving congestion and pain.
• Acute exacerbations of chronic bronchitis: controls bacterial flare‑ups and helps restore normal breathing.
• Skin and soft‑tissue infections: eradicates susceptible bacteria causing cellulitis, impetigo and wound infections.
• Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance as part of triple‑therapy regimens.
• Atypical mycobacterial infections: provides activity against certain non‑tuberculous mycobacteria.

• Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing translocation of the peptidyl‑tRNA. This action blocks the elongation of the nascent peptide chain, halting bacterial growth and leading to bacteriostatic or bactericidal effects depending on the organism and concentration.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools, sometimes watery.
• Abdominal pain: cramping or discomfort.
• Taste disturbance: altered or metallic taste.
• Vomiting: occasional emesis.
• Headache: mild to moderate headache.

Serious or Rare Side Effects

• Severe allergic reactions: rash, swelling, anaphylaxis.
• Clostridioides difficile‑associated diarrhea: severe colitis.
• Liver enzyme elevation: hepatitis or jaundice.
• QT interval prolongation: risk of cardiac arrhythmias.
• Arrhythmias: ventricular tachycardia or torsades de pointes.
• Anaphylaxis: life‑threatening hypersensitivity.

Before prescribing Klacid, clinicians should consider several safety measures.

• Renal function assessment: adjust use in patients with impaired kidney function.
• Liver monitoring: check hepatic enzymes during prolonged therapy.
• QT prolongation risk: avoid in patients with known cardiac conduction disorders.
• Hypersensitivity check: do not use in individuals with known macrolide allergy.
• Concomitant medication review: evaluate for potential drug‑drug interactions.
• Store at ambient temperature: keep in the original container, protect from moisture.

Clarithromycin interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid)

• Cisapride and pimozide: risk of serious cardiac arrhythmias.
• Simvastatin and other CYP3A4 substrates: increased statin levels leading to myopathy.
• Ergot alkaloids: potential ergotism due to elevated plasma concentrations.
• Colchicine: heightened toxicity, especially in renal impairment.

Moderate Interactions (Monitor Closely)

• Antacids containing aluminum or magnesium: may reduce clarithromycin absorption.
• Digoxin: possible increase in serum digoxin levels.
• Oral contraceptives: may reduce contraceptive efficacy, requiring additional methods.